1993
DOI: 10.1001/archfami.2.9.929
| |Summarize |Cite
|
Sign up to set email alerts

Terazosin in the treatment of benign prostatic hyperplasia. Terazosin Benign Prostatic Hyperplasia Study Group

Search citation statements

Order By: Relevance

Paper Sections

Select...
68
3
2
2

Citation Types

2
33
0
3

Year Published

Range
1994
1994
2024
2024

Publication Types

Select...
67
7
1

Relationship

0
75

Authors

Journals

Cited by 75 publications

(38 citation statements)

References 0 publications

2
33
0
3
Order By: Relevance
How the paper below cites the one you are viewing
“…In contrast, the blood pressure effects of tamsulosin were similar to those of placebo in controlled studies, both in normotensive and in hypertensive patients [10]. The blood pressure reductions seen with tamsulosin for patients without concomitant disease in the present study were similar to those previously reported for tamsulosin or placebo in the BPO population [10, 19, 21]. In the multiple regression analysis of the present study, the blood pressure-lowering of tamsulosin was almost completely explained by baseline blood pressure values.…”
Section: Discussion
supporting
confidence: 88%